|
(P1383) |
mir-181b alters tissue factor splicing and thereby reduces thrombogenicity in diabetes |
| |
|
M. Witkowski, A. Eisenreich, A. Chakraborty, A. Weithäuser, B. Stratmann, D. Tschöpe, U. Landmesser, U. Rauch-Kröhnert (Berlin, Bad Oeynhausen) |
|
(P1384) |
Blood platelets contribute to the formation of Amyloid deposits in cerebral vessels via integrin αIIbβ3 induced outside-in signaling and clusterin release |
| |
|
L. Donner, K. Fälker, S. Klinker, L. Gremer, G. Pagani, B. Bomke, H. Gohlke, D. Willbold, M. Grenegard, M. Elvers (Düsseldorf, Jülich; Örebro, SE) |
|
(P1385) |
Microvesicles and coagulation: the impact on clot formation and lysis |
| |
|
A. Savvaidis, K. Lysaja, R. Stöhr, N. Marx, K. Schütt (Aachen) |
|
(P1386) |
Increased platelet reactivity and coagulation factor XI are responsible of modifications of thrombin generation in patients with uncontrolled arterial hypertension. |
| |
|
J. Lagrange, Y. Weihert, T. Münzel, S. Karbach, P. Wenzel (Mainz) |
|
(P1387) |
Three-Dimensional and Real-Time Imaging of Embryonic Platelets Originating From Fetal Liver Megakaryocytes |
| |
|
M. Orban, K. Bierl, C. Stremmel, M. Lorenz, S. Dietzel, S. Massberg (München, Planegg-Martinsried) |
|
(P1388) |
Doxepine inhibits GPVI-dependent platelet Ca2+ signaling and collagen-dependent thrombus formation |
| |
|
R. Tegtmeyer, P. Münzer, S. Geue, M. Schaub, B. Walker-Allgaier, F. Lang, M. Gawaz, O. Borst (Tübingen) |